6.35 pm | 14 Nov 2011 |  Source: CNBC-TV18

Chairman and managing director of Cipla, YK Hamied, tells CNBC-TV18 that they intend to increase the ratio of exports to total sales so as to avail th...

5.11 pm | 30 Jun 2011 |  Source: CNBC-TV18

A US District Court has ordered the seizure of a drug made by Cipla and sold by Velecra. S Radhakrishnan, CFO, Cipla has clarified on CNBC-TV18 that t...

3.16 pm | 18 May 2011 |  Source: CNBC-TV18

In an interview with CNBC-TV18, S Radhakrishnan, CFO, Cipla says, DEPB related income in FY11. He further says, the company will see marginal impact o...

4.50 pm | 05 May 2011 |  Source: CNBC-TV18

Rationalising the company's dismal performance during the quarter, chairman and managing director YK Hamied said that the special economic zone (SEZ) ...

12.50 pm | 04 Apr 2011 |  Source: CNBC-TV18

Domestic pharma giant Cipla has taken the route of applying for a "voluntary license" for Merck's HIV Isentress (a generic raltegravir) saying it is n...

11.33 am | 03 Mar 2011 |  Source: CNBC-TV18

Speaking to CNBC-TV18, S Radhakrishnan, whole-time director of pharma major Cipla said new MAT charge will impact the company's cash flows....

11.40 am | 08 Feb 2011 |  Source: CNBC-TV18

In an interview with CNBC-TV18, S Radhakrishnan, Wholetime Director, Cipla, speaks about the results and gives his outlook going forward....

3.12 pm | 28 Jan 2011 |  Source: CNBC-TV18

In an exclusive interview with CNBC-TV18’s Ekta Batra and Reema Tendulkar, S Radhakrishnan, Wholetime Director of Cipla denies rumours of any kind of ...

4.27 pm | 22 Jan 2011 |  Source: CNBC-TV18

Kamal Sharma, Managing Director of Lupin, started four decades ago almost as a stockiest and C&F agent. Today, his company is one of India’s largest d...